Get a Sample
Schedule a Meeting
Get a Sample
Table Of Content
June 2025
The continuous glucose monitoring device market size is recorded at USD 5.74 billion in 2025 and is projected to reach around USD 10.65 billion by 2034, expanding at a CAGR of 7% from 2025 to 2034. The North America continuous glucose monitoring device market size reached USD 2.20 billion in 2024 and is expanding at a CAGR of 7.04% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The continuous glucose monitoring device market size accounted for USD 5.36 billion in 2024 and is predicted to reach around USD 10.65 billion by 2034, growing at a CAGR of 7% from 2025 to 2034.
The U.S. continuous glucose monitoring device market was valued at USD 1.46 billion in 2024 and is projected to grow around USD 2.93 billion by 2034, growing at a CAGR of 7.19% between 2025 to 2034.
Based on region, North America accounted for around 39% of the market share in 2024. This is simply attributed to the high literacy rate, increased disposable income, increased healthcare expenditure, increased adoption rate of latest technologies, increased awareness regarding diabetes, growing geriatric population, and higher demand for the diabetes preventive measures in the major markets like US and Canada. In North America, Canada is the fastest-growing market, owing to the rising cases of diabetes. According to the Diabetes Canada, around 11 million people were suffering from diabetes in 2020, and this number is expected to rise in the future.
North America dominated the continuous glucose monitoring (CGM) devices market due to technological advancements in healthcare infrastructure and awareness regarding optimization of government and private insurance policies. The advanced infrastructure provides individuals with the topmost clinical facility that helps prevent diseases like diabetes and cancer.
Early detection assists in identifying and prescribing medication for rare diseases, and CGM devices significantly improve the prevention of diseases, as they provide real-time tracking of blood sugar levels and continuously measure glucose levels in the interstitial fluid. In addition, Canada also plays a crucial role as it provides patients with government initiatives and promotes awareness regarding the advantages of glucose monitoring.
What to Expect in U.S. Glucose Monitoring Device Market?
The growing prevalence of diabetes in the country increases demand for continuous glucose monitoring devices. For instance, according to the National Diabetes Statistics Report in 2021 total of 38.4 million people had diabetes. The presence of robust infrastructure for managing diabetes and a well-established healthcare system helps in the market growth. The growing adoption of innovative healthcare technologies and favorable reimbursement policies drives the market growth. The growing awareness about continuous glucose monitoring among healthcare providers and patients drives the overall growth of the market.
The Asia Pacific is estimated to be the most opportunistic market during the forecast period. Asia Pacific presets a lucrative growth opportunity to the market players. The presence of huge population, rising urban population, rising healthcare expenditure, rising awareness regarding diabetes, and unhealthy food habits are the major factors that are altogether augmenting the growth of the continuous blood glucose monitoring device market.
In Asia Pacific, the continuous glucose monitoring (CGM) devices market is also experiencing rapid growth, fueled by a combination of factors including a diverse and growing patient population base of diabetes patients, the presence of real-time tracking devices, smart handheld devices, and an increasing emphasis on an automated insulin delivery system. These dynamics contribute to the region's elevated demand for insulin delivery devices, particularly among patients with glucose levels that drop too low (hypoglycemia) or rise too high (hyperglycemia).
Asia Pacific consumers exhibit a wide range of preferences, from those seeking affordable insulin devices to those desiring personalized smart devices that provide 24/7 monitoring, such as implantable CGMs and intermittently scanned CGMs. Moreover, India is home to numerous digital healthcare solutions and government initiatives, which reinforce a strong presence in the market for high-quality CGM devices.
China Continuous Glucose Monitoring (CGM) Device Market Trends:
China is a major contributor to the continuous glucose monitoring device market. The growing diabetic population in the nation increases demand for an efficient tool like a continuous glucose monitoring device. The growing awareness about diabetes through various programs like community outreach and health campaigns, and educational programs helps in the market growth. The growing geriatric population and technological advancements in CGM devices drive the overall growth of the market.
India Continuous Glucose Monitoring (CGM) Device Market Trends:
India is significantly growing in the continuous glucose monitoring market. The growing adult diabetes population in the nation increases demand for CGM devices. The high prevalence of diabetes 2 helps in the market growth. The growing awareness about the advantages of CGM devices increases the adoption of CGM devices. The growing prevalence of diabetes and the rising trend of preventive healthcare fuel demand for CGM devices. The aging population and the growing diabetes in older people drive the overall growth of the market.
The global continuous glucose monitoring device market is primarily driven by the rising prevalence of diabetes and increasing demand for the treatment and preventive measures across the globe. According to the World Health Organization, around 1.5 million deaths were directly linked to the diabetes in 2019 and around 2.2 million deaths were linked to high blood glucose in 2012. According to the International Diabetes Federation, around 700 million people will have diabetes around the globe, by 2045. Therefore, the alarming rise in the diabetic population globally is expected to drive the demand for the CGM device in the forthcoming years. Furthermore, the growing geriatric population is a significant factor that will augment the demand for the CGM device. Geriatric people are prone to high blood glucose levels and diabetes. The rising awareness regarding the diabetes, availability of CGM devices, increasing disposable income, and increasing expenditure in the healthcare are the significant factors that are estimated to augment the global CGM device market in the foreseeable future.
Overweight and obesity are the two major causes of diabetes. Moreover, the unhealthy food habits among the population have contributed in the growth of the number of obese people. According to the World Health Organization, more than 1.9 billion global populations were overweight, out of which around 650 million adults were obese in 2016. The CGM device tracks the glucose levels and continuously monitors it using latest technologies like sensors and wireless connectivity, which helps in the proper management of the blood glucose levels. The aggressive marketing by the prominent players in the developed and developing markets had augmented the demand for CGM devices by spreading the awareness regarding the glucose monitoring. All these factors are expected to have a positive impact on the global continuous blood glucose monitoring device market.
| Report Highlights | Details |
| Market Size by 2034 | USD 10.65 Billion |
| Market Size in 2025 | USD 5.74 Billion |
| Market Size in 2024 | USD 5.36 Billion |
| Market Growth Rate from 2025 to 2034 | CAGR of 7% |
| Largest Market | North America |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | End User, Component, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
The sensors segment accounted for around 40.5% of the market share in 2024. This is attributed to the accuracy and efficiency of the sensors in analyzing the blood glucose levels. Moreover, higher preference for the sensors has augmented the growth of this segment. It efficiently reads the fluctuations in the blood glucose levels which makes sensor the dominating segment in the CGM device market. The technological advancements in the sensors technology has improved the performance of the sensors. The advancements in the sensor technology has resulted in increasing the affordability of the sensor CGM devices, thereby opening growth prospects in the developing and the underdeveloped economies across the globe.
The home healthcare segment accounted for around 45% of the market share in 2024. This can be attributed to the rising prevalence of diabetes, increased awareness regarding the availability of CGM devices, increasing disposable income, and increased demand for the preventive measures among the consumers. The increasing health consciousness and rising awareness regarding the management of blood glucose levels on regular basis has augmented the demand for the CGM device at home healthcare segment. Moreover, aggressive marketing strategies adopted by the top market players have exponentially contributed towards the growth of this segment.
The other segment is estimated to be the most opportunistic segment during the forecast period. The rising penetration of clinics and diagnostic labs across the globe is a major factor that boosts the demand for the CGM devices. Moreover, low literacy in the low and middle income countries makes the diabetic population dependent on the clinics and diagnostic labs for the continuous blood glucose monitoring, which is a major factor for the growth of the others segment.
The market is moderately fragmented with the presence of several local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers. Companies are also spending on the development of improved products. Moreover, they are also focusing on maintaining competitive pricing.
The various developmental strategies like mergers, acquisitions, and partnerships foster market growth and offers lucrative growth opportunities to the market players.
Roche
Eversense
Abbott
By Component
By End User
By Demographics
By Region
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
June 2025
June 2025
July 2024
October 2024